Shen Feng

Shanghai Shenfeng Biological Technology is a prominent Chinese biotechnology firm focused on the development and commercialization of in vitro diagnostic (IVD) products. Established in 2002, the company has built a robust portfolio centered on molecular diagnostics and immunology, particularly for infectious disease screening. Their flagship products include Interferon-Gamma Release Assays (IGRA) for tuberculosis (TB) infection and a variety of PCR-based kits for detecting pathogens such as Mycobacterium tuberculosis, Hepatitis B, and Hepatitis C. Shenfeng Biological operates a large-scale manufacturing facility in Shanghai that adheres to international quality standards. The company serves a wide network of hospitals, blood centers, and disease control agencies, playing a critical role in China's public health infrastructure.